Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding a Phase II trial for MMR-proficient colorectal cancer and the addition of a new revision number and collaborators.SummaryDifference45%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.